 |
Arrize US Tech Fund is an early-stage venture fund, investing in innovative medical technologies developed in the US (North America) only. The areas of investment include but not limit to medical devices, in vitro diagnostics, genetic engineering, pharmaceuticals, bio-therapeutics, and AI and bioinformatics etc. Our seasoned fund managers have deep life science background and extensive and successful industrial experience. We are very well connected in US health tech industry to have continuous and often very exclusive deal flow. The fund's invested targets are all at the world cutting-edge of innovation or often disruptive in their respective fields. The fund's value has appreciated significantly since its inception and early redemptions are very likely. For further information about this fund, you can visit www.arrizecapital.com. |
